4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-25-000006
Director sold 6,250 shares at an average $85.11 ($531,963)
- Director acquired 6,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loxam Teri Director | 2025-01-15 | Option exercise 10b5-1 | +6,250 | $22.70 | $141,875 | 13,425 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −146 | $80.46 | $11,747 | 13,279 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −215 | $81.53 | $17,530 | 13,064 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −1,136 | $82.89 | $94,168 | 11,928 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −1,202 | $83.93 | $100,885 | 10,726 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −1,043 | $85.29 | $88,961 | 9,683 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −966 | $86.26 | $83,324 | 8,717 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −1,013 | $87.38 | $88,513 | 7,704 | D |
| Loxam Teri Director | 2025-01-15 | Sale 10b5-1 | −529 | $88.54 | $46,836 | 7,175 | D |
| Derivatives | |||||||
| Loxam Teri Director | 2025-01-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,250 | 6,250 | D | ||
| Open-market sales · 6,250 sh · avg $85.11 · $531,963 | |||||||
Loading xslF345X05/wk-form4_1737147935.xml…